Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: Study protocol for a randomised controlled trial (ELAD study) (Trials. (2019) 20 (191) DOI: 10.1186/s13063-019-3259-x)

8Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

After publication of our article [1] the authors have notified us that the name of Prof. Christian Hölscher had been inadvertently forgotten when compiling the list of authors. Dr. Hölscher developed the concept of testing liraglutide in Alzheimer’s mouse model, has done the preclinical experiments, and is a co-applicant of the Alzheimer ociety UK grant that partially funds the study.

Cite

CITATION STYLE

APA

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., … Edison, P. (2020, July 19). Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: Study protocol for a randomised controlled trial (ELAD study) (Trials. (2019) 20 (191) DOI: 10.1186/s13063-019-3259-x). Trials. BioMed Central Ltd. https://doi.org/10.1186/s13063-020-04608-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free